Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer

摘要

The aim of this study was to evaluate the correlation of long non-coding RNAs (lncRNAs) taurine-upregulated gene 1 (TUG1) with clinicopathological characteristics as well as overall survival (OS) in epithelial ovarian cancer (EOC) patients, and investigate its function in EOC cells proliferation and apoptosis in vitro. LncRNA TUG1 expressions were detected in tumor tissues and paired adjacent tissues obtained from 96 EOC patients. Blank mimic, lncRNA TUG1 mimic, blank inhibitor, and lncRNA TUG1 inhibitor plasmids were transfected into SKOV3 cells. CKK-8, annexin V-FITC–propidium iodide, qPCR and western blot assays were performed to detect cells proliferation , cells apoptosis , RNA expression, and protein expression, respectively. LncRNA TUG1 expression was higher in tumor tissue compared to paired adjacent tissue ( P < .001), and it was positively correlated with pathological grade ( P = .022), tumor size ( P = .011) and FIGO stage ( P < .001). Kaplan-Meier curve showed that lncRNA TUG1 high expression was associated with worse OS ( P = .003). Multivariate Cox analysis indicated that lncRNA TUG1 high expression (vs. low expression) ( P = .035) was independently predictive factor for shorter OS. In vitro, cells proliferation was promoted after treatment with lncRNA TUG1 mimic and was suppressed after treatment with lncRNA TUG1 inhibitor. In addition, cells apoptosis rate was decreased in lncRNA TUG1 mimic group compared to NC1 mimic, and increased in lncRNA TUG1 inhibitor group compared to NC2 inhibitor. In conclusion, lncRNA TUG1 is positively correlated with advanced disease and poor prognosis , and it promotes cells proliferation and inhibits cells apoptosis in EOC cells.